| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | soluble NSF attachment protein activity | 2.07e-05 | 3 | 53 | 2 | GO:0005483 | |
| GeneOntologyMolecularFunction | integrin binding involved in cell-matrix adhesion | 6.88e-05 | 5 | 53 | 2 | GO:0098640 | |
| GeneOntologyMolecularFunction | cell-matrix adhesion mediator activity | 2.46e-04 | 9 | 53 | 2 | GO:0098634 | |
| GeneOntologyBiologicalProcess | SNARE complex disassembly | 1.94e-05 | 3 | 53 | 2 | GO:0035494 | |
| GeneOntologyCellularComponent | synaptobrevin 2-SNAP-25-syntaxin-1a complex | 6.28e-05 | 5 | 53 | 2 | GO:0070044 | |
| Domain | Sushi | 1.41e-05 | 52 | 53 | 4 | PF00084 | |
| Domain | CCP | 1.65e-05 | 54 | 53 | 4 | SM00032 | |
| Domain | SUSHI | 1.90e-05 | 56 | 53 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.04e-05 | 57 | 53 | 4 | IPR000436 | |
| Domain | NSF_attach | 2.37e-05 | 3 | 53 | 2 | IPR000744 | |
| Domain | ZINC_FINGER_C2H2_2 | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF804B ZNF727 ZNF736 ZNF841 ZNF285 | 5.51e-05 | 775 | 53 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF804B ZNF727 ZNF736 ZNF841 ZNF285 | 5.63e-05 | 777 | 53 | 10 | PS00028 |
| Domain | Znf_C2H2-like | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF804B ZNF727 ZNF736 ZNF841 ZNF285 | 6.89e-05 | 796 | 53 | 10 | IPR015880 |
| Domain | Znf_C2H2 | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF804B ZNF727 ZNF736 ZNF841 ZNF285 | 7.57e-05 | 805 | 53 | 10 | IPR007087 |
| Domain | ZnF_C2H2 | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF804B ZNF727 ZNF736 ZNF841 ZNF285 | 7.81e-05 | 808 | 53 | 10 | SM00355 |
| Domain | Protocadherin | 7.86e-05 | 5 | 53 | 2 | PF08374 | |
| Domain | Protocadherin | 7.86e-05 | 5 | 53 | 2 | IPR013585 | |
| Domain | CAP_GLY | 3.50e-04 | 10 | 53 | 2 | PF01302 | |
| Domain | CAP_GLY_1 | 3.50e-04 | 10 | 53 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 3.50e-04 | 10 | 53 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 3.50e-04 | 10 | 53 | 2 | IPR000938 | |
| Domain | CAP_GLY | 3.50e-04 | 10 | 53 | 2 | SM01052 | |
| Domain | - | 3.50e-04 | 10 | 53 | 2 | 2.30.30.190 | |
| Domain | KRAB | 5.11e-04 | 358 | 53 | 6 | PS50805 | |
| Domain | KRAB | 5.11e-04 | 358 | 53 | 6 | PF01352 | |
| Domain | KRAB | 5.99e-04 | 369 | 53 | 6 | SM00349 | |
| Domain | KRAB | 6.08e-04 | 370 | 53 | 6 | IPR001909 | |
| Domain | - | 6.11e-04 | 679 | 53 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 6.98e-04 | 693 | 53 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 7.05e-04 | 694 | 53 | 8 | IPR013087 | |
| Domain | Cadherin_2 | 8.32e-04 | 65 | 53 | 3 | PF08266 | |
| Domain | Cadherin_N | 8.32e-04 | 65 | 53 | 3 | IPR013164 | |
| Domain | Peptidase_M14 | 1.92e-03 | 23 | 53 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 1.92e-03 | 23 | 53 | 2 | IPR000834 | |
| Domain | zf-C2H2_6 | 1.93e-03 | 314 | 53 | 5 | PF13912 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PF00632 | |
| Domain | HECTc | 2.65e-03 | 27 | 53 | 2 | SM00119 | |
| Domain | HECT_dom | 2.65e-03 | 27 | 53 | 2 | IPR000569 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PS50237 | |
| Domain | Cadherin_CS | 3.66e-03 | 109 | 53 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 4.05e-03 | 113 | 53 | 3 | PS00232 | |
| Domain | Cadherin | 4.05e-03 | 113 | 53 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 4.16e-03 | 114 | 53 | 3 | PS50268 | |
| Domain | - | 4.16e-03 | 114 | 53 | 3 | 2.60.40.60 | |
| Domain | CA | 4.26e-03 | 115 | 53 | 3 | SM00112 | |
| Domain | Cadherin-like | 4.36e-03 | 116 | 53 | 3 | IPR015919 | |
| Domain | Cadherin | 4.58e-03 | 118 | 53 | 3 | IPR002126 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 24311785 | ||
| Pubmed | SNAP family of NSF attachment proteins includes a brain-specific isoform. | 7.09e-06 | 3 | 54 | 2 | 8455721 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 9695844 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 8013662 | ||
| Pubmed | 1.26e-05 | 29 | 54 | 3 | 14563677 | ||
| Pubmed | The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1. | 1.42e-05 | 4 | 54 | 2 | 35802072 | |
| Pubmed | 1.70e-05 | 32 | 54 | 3 | 23049088 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 1315316 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 22654117 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 8468048 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 18541031 | ||
| Pubmed | Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes. | 3.54e-05 | 6 | 54 | 2 | 9817754 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 9697855 | ||
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 6.20e-05 | 49 | 54 | 3 | 9630514 | |
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 14755058 | ||
| Pubmed | Seven novel mammalian SNARE proteins localize to distinct membrane compartments. | 8.46e-05 | 9 | 54 | 2 | 9553086 | |
| Pubmed | Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. | 1.06e-04 | 10 | 54 | 2 | 25173105 | |
| Pubmed | Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. | 1.06e-04 | 10 | 54 | 2 | 9914469 | |
| Pubmed | SNARE protein recycling by αSNAP and βSNAP supports synaptic vesicle priming. | 1.06e-04 | 10 | 54 | 2 | 21040848 | |
| Pubmed | Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. | 1.08e-04 | 59 | 54 | 3 | 17330941 | |
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 1.29e-04 | 11 | 54 | 2 | 15905963 | |
| Pubmed | 1.48e-04 | 1285 | 54 | 9 | 35914814 | ||
| Pubmed | 1.83e-04 | 181 | 54 | 4 | 37372979 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.12e-04 | 74 | 54 | 3 | 10817752 | |
| Pubmed | 2.39e-04 | 77 | 54 | 3 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.67e-04 | 80 | 54 | 3 | 10716726 | |
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 14758363 | ||
| Pubmed | 3.42e-04 | 87 | 54 | 3 | 12465718 | ||
| Pubmed | 5.93e-04 | 105 | 54 | 3 | 30280653 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 7.51e-04 | 26 | 54 | 2 | 26949039 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 9.59e-04 | 736 | 54 | 6 | 29676528 | |
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 1.14e-03 | 32 | 54 | 2 | 22424883 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 1.33e-03 | 139 | 54 | 3 | 25476789 | |
| Pubmed | 1.36e-03 | 35 | 54 | 2 | 25977363 | ||
| Pubmed | Choroid plexuses carry nodal-like cilia that undergo axoneme regression from early adult stage. | 1.36e-03 | 35 | 54 | 2 | 37890489 | |
| Cytoband | 10p11.2 | 3.79e-05 | 8 | 54 | 2 | 10p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 5.77e-04 | 137 | 54 | 3 | chr9q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q31 | 3.57e-03 | 75 | 54 | 2 | chr1q31 | |
| Cytoband | 7q11.21 | 4.35e-03 | 83 | 54 | 2 | 7q11.21 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.72e-06 | 57 | 39 | 4 | 1179 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZHX3 ZNF627 ZNF493 ZNF37A ZNF337 ZNF727 ZNF736 ZNF841 ZNF285 | 1.70e-05 | 718 | 39 | 9 | 28 |
| GeneFamily | Non-clustered protocadherins | 2.95e-04 | 12 | 39 | 2 | 21 | |
| GeneFamily | Ubiquitin specific peptidases | 6.49e-03 | 56 | 39 | 2 | 366 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-08 | 169 | 54 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 176 | 54 | 5 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 192 | 54 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.94e-05 | 157 | 54 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.04e-05 | 158 | 54 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.28e-05 | 177 | 54 | 4 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 7.15e-05 | 183 | 54 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-05 | 190 | 54 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-05 | 190 | 54 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.43e-05 | 191 | 54 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.60e-05 | 192 | 54 | 4 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-05 | 193 | 54 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-05 | 194 | 54 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.95e-05 | 194 | 54 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.95e-05 | 194 | 54 | 4 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.13e-05 | 195 | 54 | 4 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.13e-05 | 195 | 54 | 4 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 196 | 54 | 4 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 196 | 54 | 4 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 196 | 54 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 196 | 54 | 4 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.50e-05 | 197 | 54 | 4 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.88e-05 | 199 | 54 | 4 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.88e-05 | 199 | 54 | 4 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.88e-05 | 199 | 54 | 4 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A | 6.55e-06 | 198 | 53 | 6 | 4007_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 6.55e-06 | 198 | 53 | 6 | 6965_UP | |
| Disease | pathological myopia | 4.82e-05 | 111 | 53 | 4 | EFO_0004207 | |
| Disease | gluteofemoral adipose tissue measurement | 9.45e-05 | 132 | 53 | 4 | EFO_0803317 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.04e-04 | 260 | 53 | 5 | EFO_0008317 | |
| Disease | respiratory symptom measurement, COVID-19 | 3.24e-04 | 74 | 53 | 3 | EFO_0007939, MONDO_0100096 | |
| Disease | amygdala volume change measurement | 3.74e-04 | 16 | 53 | 2 | EFO_0021490 | |
| Disease | open-angle glaucoma | 3.89e-04 | 191 | 53 | 4 | EFO_0004190 | |
| Disease | phosphatidylcholine 40:6 measurement | 4.23e-04 | 17 | 53 | 2 | EFO_0010389 | |
| Disease | triacylglycerol 58:9 measurement | 7.15e-04 | 22 | 53 | 2 | EFO_0010443 | |
| Disease | malaria | 8.29e-04 | 102 | 53 | 3 | EFO_0001068 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 1.00e-03 | 26 | 53 | 2 | EFO_0009944 | |
| Disease | complement factor H-related protein 2 measurement | 1.25e-03 | 29 | 53 | 2 | EFO_0600055 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.42e-03 | 31 | 53 | 2 | EFO_0022249 | |
| Disease | Kartagener Syndrome | 1.81e-03 | 35 | 53 | 2 | C0022521 | |
| Disease | Polynesian Bronchiectasis | 1.81e-03 | 35 | 53 | 2 | C4317124 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.81e-03 | 35 | 53 | 2 | C4551906 | |
| Disease | reticulocyte count | 2.55e-03 | 1045 | 53 | 7 | EFO_0007986 | |
| Disease | complement factor H-related protein 5 measurement | 2.60e-03 | 42 | 53 | 2 | EFO_0008098 | |
| Disease | glaucoma | 2.70e-03 | 154 | 53 | 3 | MONDO_0005041 | |
| Disease | triglycerides in large LDL measurement | 2.73e-03 | 43 | 53 | 2 | EFO_0022319 | |
| Disease | Primary Ciliary Dyskinesia | 3.25e-03 | 47 | 53 | 2 | C4551720 | |
| Disease | total lipids in lipoprotein particles measurement | 3.39e-03 | 48 | 53 | 2 | EFO_0022309 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YGCDGSDRSKTLYLQ | 471 | Q8NEM8 | |
| KLGSTITYQCDSGYK | 1581 | Q96PZ7 | |
| TGSNAAQYKYGKNRV | 546 | Q8N556 | |
| YAGNYSGGNKRKLST | 2041 | O95477 | |
| KAKYGTNYRVGSSAD | 271 | Q8IVL8 | |
| SYKSYCKNGVNGTGE | 396 | P05556 | |
| TCYKSKGYRPVNSGN | 401 | Q7Z3Y9 | |
| YKYTKQDGECGTLSK | 16 | Q5D862 | |
| GCNGLSYTLEYTKTK | 56 | Q9BUE6 | |
| SGKYGYKSTFCSQDI | 441 | Q17RR3 | |
| YRKSSGAKCVYQLRG | 3731 | Q15751 | |
| NGDKVTYACKSGYLL | 356 | P05160 | |
| GENDTGLCYNSKMKY | 136 | Q9NZN1 | |
| SNQTRTYDGDGYKKR | 6 | O95989 | |
| YCRQREAKSGYQAGK | 876 | Q08174 | |
| ARYCRSKNKNGYEAG | 901 | O60245 | |
| YSQKAFCGIYSKDGQ | 171 | Q8TEB1 | |
| KVSQNGYKFLYCSAR | 711 | Q14693 | |
| VRGNGSLTKTYCYKA | 781 | Q9Y5I4 | |
| TYSNRKENKGGYLCH | 986 | Q8NFZ0 | |
| KGCTYEGNTYNSSFK | 106 | Q8N8U9 | |
| YKYRSKPACASQEGS | 96 | Q96BT1 | |
| GRSQKQGAGAYSKSY | 2036 | Q8TD84 | |
| QDKRYTNKYSSQFGG | 51 | O15371 | |
| YEGRYCIFNNKTNSK | 161 | Q8ND71 | |
| KCLYESSLGGAYKQL | 561 | O15033 | |
| QYKCKPGYATADGNS | 361 | Q92496 | |
| VCKERQALYQSKGYS | 336 | Q96A59 | |
| GYDSYGNICGQKNTK | 61 | Q8WWI5 | |
| DYKSCGNIYKGLAQT | 1901 | Q9NYC9 | |
| LQCVKGANAKSYYQS | 771 | Q86Y56 | |
| KKGIQGHYNSCYLDS | 591 | Q9NQC7 | |
| GYSCYQNSKGSDRIK | 51 | Q8WUB2 | |
| CKAVAGYKCTGYRSQ | 166 | Q9BRP7 | |
| IAKCNGKYLSSNYSE | 311 | O75751 | |
| YYKGEESNSSANKCL | 151 | P54920 | |
| GSKVTYRCNKGYTLA | 1866 | Q4LDE5 | |
| RGYTGQKTCKYTEHG | 166 | P17032 | |
| DYQRVGNCKGQKSSY | 116 | A8MUV8 | |
| SKVSGCGNQRYKRYS | 686 | A4D1E1 | |
| GSVNGKRYFECQAKY | 206 | Q99426 | |
| YSKRTAYQKAGGDSG | 836 | Q96K76 | |
| SNRVCSQYAAYGEKK | 216 | P02774 | |
| YQEYGKKSYTRNQCG | 131 | Q7L945 | |
| KKSYTRNQCGRALSY | 136 | Q7L945 | |
| YYKGEESNSSANKCL | 151 | Q9H115 | |
| KYTQSNSVCYAKNGQ | 426 | P31939 | |
| YKCNECGKSYISRSG | 761 | Q6ZN19 | |
| GEKSYKYECGKSFNQ | 106 | Q6ZR52 | |
| AQSYKLYRCGSVKDG | 126 | Q8N9V3 | |
| NGHRSTLDGYLYSCK | 66 | Q9H4I2 | |
| GEKSYKCDQYGKNFS | 256 | Q96NJ3 | |
| QECGRKFSNKSYYSK | 716 | Q9Y3M9 | |
| DYQSVGNCKGQKSSY | 116 | B4DX44 | |
| KIQSHCSYTYGRKGE | 1676 | Q13459 |